» Articles » PMID: 29666146

Identification of Circadian Clock Modulators from Existing Drugs

Abstract

Chronic circadian disruption due to shift work or frequent travel across time zones leads to jet-lag and an increased risk of diabetes, cardiovascular disease, and cancer. The development of new pharmaceuticals to treat circadian disorders, however, is costly and hugely time-consuming. We therefore performed a high-throughput chemical screen of existing drugs for circadian clock modulators in human U2OS cells, with the aim of repurposing known bioactive compounds. Approximately 5% of the drugs screened altered circadian period, including the period-shortening compound dehydroepiandrosterone (DHEA; also known as prasterone). DHEA is one of the most abundant circulating steroid hormones in humans and is available as a dietary supplement in the USA Dietary administration of DHEA to mice shortened free-running circadian period and accelerated re-entrainment to advanced light-dark (LD) cycles, thereby reducing jet-lag. Our drug screen also revealed the involvement of tyrosine kinases, ABL1 and ABL2, and the BCR serine/threonine kinase in regulating circadian period. Thus, drug repurposing is a useful approach to identify new circadian clock modulators and potential therapies for circadian disorders.

Citing Articles

Modulatory effects of cinnamomi cortex and its components epicatechin and linalool on skin circadian rhythms.

Kim J, Lee J, Lee S, Jung E, Lee K Sci Rep. 2025; 15(1):4480.

PMID: 39915616 PMC: 11803083. DOI: 10.1038/s41598-025-88325-5.


Circadian Effects of Melatonin Receptor-Targeting Molecules In Vitro.

Chhe K, Hegde M, Taylor S, Farkas M Int J Mol Sci. 2025; 25(24.

PMID: 39769270 PMC: 11727910. DOI: 10.3390/ijms252413508.


Oak extracts modulate circadian rhythms of clock gene expression in vitro and wheel-running activity in mice.

Haraguchi A, Du Y, Shiraishi R, Takahashi Y, Nakamura T, Shibata S Sleep Biol Rhythms. 2024; 20(2):255-266.

PMID: 38469255 PMC: 10899999. DOI: 10.1007/s41105-021-00365-2.


The Suprachiasmatic Nucleus at 50: Looking Back, Then Looking Forward.

Ono D, Weaver D, Hastings M, Honma K, Honma S, Silver R J Biol Rhythms. 2024; 39(2):135-165.

PMID: 38366616 PMC: 7615910. DOI: 10.1177/07487304231225706.


TimeTeller for timing health: The potential of circadian medicine to improve performance, prevent disease and optimize treatment.

Dose B, Yalcin M, Dries S, Relogio A Front Digit Health. 2023; 5:1157654.

PMID: 37153516 PMC: 10155816. DOI: 10.3389/fdgth.2023.1157654.


References
1.
Lemos D, Downs J, Urbanski H . Twenty-four-hour rhythmic gene expression in the rhesus macaque adrenal gland. Mol Endocrinol. 2006; 20(5):1164-76. DOI: 10.1210/me.2005-0361. View

2.
Zhang E, Liu A, Hirota T, Miraglia L, Welch G, Pongsawakul P . A genome-wide RNAi screen for modifiers of the circadian clock in human cells. Cell. 2009; 139(1):199-210. PMC: 2777987. DOI: 10.1016/j.cell.2009.08.031. View

3.
Takahashi J . Molecular components of the circadian clock in mammals. Diabetes Obes Metab. 2015; 17 Suppl 1:6-11. PMC: 4560116. DOI: 10.1111/dom.12514. View

4.
Mintz E, Marvel C, Gillespie C, Price K, Albers H . Activation of NMDA receptors in the suprachiasmatic nucleus produces light-like phase shifts of the circadian clock in vivo. J Neurosci. 1999; 19(12):5124-30. PMC: 6782653. View

5.
Colwell C, Foster R, Menaker M . NMDA receptor antagonists block the effects of light on circadian behavior in the mouse. Brain Res. 1991; 554(1-2):105-10. DOI: 10.1016/0006-8993(91)90177-w. View